XYL (Xylem Inc)
Insider Trading Activity
Every open-market purchase and sale reported by XYL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | D CHRISTIAN KOCH | Director | A | — | — |
| 2026-05-15 | EARL RAY ELLIS | Director | A | — | — |
| 2026-05-15 | ROBERT F FRIEL | Director | A | — | — |
| 2026-05-15 | Lisa Glatch | Director | A | — | — |
| 2026-05-15 | Victoria D Harker | Director | A | — | — |
| 2026-05-15 | Mark D Morelli | Director | A | — | — |
| 2026-05-15 | Jerome A Peribere | Director | A | — | — |
| 2026-05-15 | Lila Tretikov | Director | A | — | — |
| 2026-05-15 | Uday Yadav | Director | A | — | — |
| 2026-05-08 | Geri-Michelle McShane | SVP, CAO | MIXED | — | — |
| 2026-05-04 | Jerome A Peribere | Director | Buy | — | — |
| 2026-03-06 | Rodney Aulick | EVP & President, WSS | F | — | — |
| 2026-03-06 | Albert Cho | EVP, Strategy | F | — | — |
| 2026-03-06 | Stacy Cozad | EVP & Chief Legal Officer | F | — | — |
| 2026-03-06 | Meredith Emmerich | EVP & Pres, AW | F | — | — |
| 2026-03-06 | William K Grogan | EVP & Chief Financial Officer | F | — | — |
| 2026-03-06 | Michael J. McGann | EVP & President, MCS | F | — | — |
| 2026-03-06 | Matthew Francis Pine | Pres. & CEO | F | — | — |
| 2026-03-06 | Hayati Yarkadas | EVP & President, WI | F | — | — |
| 2026-03-06 | Claudia S Toussaint | EVP, CP&SO | F | — | — |
| 2026-03-06 | Geri-Michelle McShane | SVP, CAO | F | — | — |
| 2026-03-03 | Geri-Michelle McShane | SVP, CAO | MIXED | — | — |
| 2026-03-03 | Hayati Yarkadas | EVP & President, WI | MIXED | — | — |
| 2026-03-03 | Claudia S Toussaint | EVP, CPSO | MIXED | — | — |
| 2026-03-03 | Rodney Aulick | EVP & President, WSS | MIXED | — | — |
| 2026-03-03 | William K Grogan | EVP & Chief Financial Officer | MIXED | — | — |
| 2026-03-03 | Michael J. McGann | EVP & President, MCS | MIXED | — | — |
| 2026-03-03 | Stacy Cozad | EVP & Chief Legal Officer | A | — | — |
| 2026-03-03 | Meredith Emmerich | EVP & Pres, AW | A | — | — |
| 2026-03-03 | Matthew Francis Pine | Pres. & CEO | MIXED | — | — |
| 2026-03-03 | Albert Cho | EVP, Strategy | MIXED | — | — |
| 2026-01-06 | Rodney Aulick | EVP & President, WSS | F | — | — |
| 2025-12-15 | Rodney Aulick | EVP & President, WSS | F | — | — |
| 2025-11-05 | Victoria D Harker | Director | Sell | — | — |
| 2025-10-31 | Claudia S Toussaint | EVP, CPSO | Sell | — | — |
| 2025-10-21 | Meredith Emmerich | EVP & Pres, AW | F | — | — |
| 2025-09-18 | William K Grogan | SVP & Chief Financial Officer | F | — | — |
| 2025-09-05 | Geri-Michelle McShane | VP, CAO | Sell | — | — |
| 2025-09-03 | Stacy Cozad | SVP & Chief Legal Officer | A | — | — |
| 2025-08-20 | Lisa Glatch | Director | Sell | — | — |
| 2025-08-05 | Victoria D Harker | Director | Sell | — | — |
| 2025-05-27 | Rodney Aulick | SVP & President, WSS | F | — | — |
| 2025-05-14 | EARL RAY ELLIS | Director | A | — | — |
| 2025-05-14 | Lisa Glatch | Director | A | — | — |
| 2025-05-14 | Victoria D Harker | Director | A | — | — |
| 2025-05-14 | ROBERT F FRIEL | Director | A | — | — |
| 2025-05-14 | Jerome A Peribere | Director | A | — | — |
| 2025-05-14 | Lila Tretikov | Director | A | — | — |
| 2025-05-14 | Mark D Morelli | Director | A | — | — |
| 2025-05-14 | Uday Yadav | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President & CEO | 401,946 | — |
| — | President & CEO | 387,212 | — |
| — | Pres. & CEO | 79,112 | — |
| — | EVP & President, WSS | 73,683 | — |
| — | SVP & GC & Corp Secretary | 61,839 | — |
| — | Director | 60,225 | — |
| — | SVP & Chief Commun. Officer | 54,938 | — |
| — | SVP, CFO | 52,529 | — |
| — | Senior Vice President | 51,543 | — |
| — | Chief Financial Officer & SVP | 49,601 | — |
| — | Director | 41,397 | — |
| — | EVP, CP&SO | 40,287 | — |
| — | Senior Vice President | 39,985 | — |
| — | EVP & Chief Financial Officer | 39,510 | — |
| — | Director | 38,706 | — |
| — | Senior Vice President | 37,292 | — |
| — | Director | 36,170 | — |
| — | Senior Vice President | 34,140 | — |
| — | EVP & President, WI | 33,540 | — |
| — | Director | 32,956 | — |
| — | Director | 30,779 | — |
| — | SVP & President, Flow Control | 30,197 | — |
| — | Senior Vice President | 27,373 | — |
| — | Director | 21,901 | — |
| — | Director | 21,498 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the XYL quote page; the site-wide leaderboard is on the insider transactions hub.